Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of ZL-82 tablets in moderate to severe atopic dermatitis
ChiCTR2500101470Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ZL-82 in atopic dermatitis (AD) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Primary: Percent change in EASI at week 16. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
ZL-82
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR2500101470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101470.